These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 33198608)

  • 1. Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.
    Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y; Johnston SC;
    Stroke; 2020 Dec; 51(12):3504-3513. PubMed ID: 33198608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Lancet Neurol; 2017 Apr; 16(4):301-310. PubMed ID: 28238711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
    Johnston SC; Amarenco P; Aunes M; Denison H; Evans SR; Himmelmann A; Jahreskog M; James S; Knutsson M; Ladenvall P; Molina CA; Nylander S; Röther J; Wang Y;
    Stroke; 2021 Nov; 52(11):3482-3489. PubMed ID: 34477459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
    Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
    N Engl J Med; 2020 Jul; 383(3):207-217. PubMed ID: 32668111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.
    Wang Y; Pan Y; Li H; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Birve F; Ladenvall P; Molina CA; Johnston SC;
    JAMA Neurol; 2021 Sep; 78(9):1091-1098. PubMed ID: 34244703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.
    Molina CA; Johnston SC; Ladenvall P; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Knutsson M; Minematsu K; Röther J; Wang Y; Wong KSL;
    Stroke; 2019 Mar; 50(3):675-682. PubMed ID: 30776996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Stroke; 2017 Sep; 48(9):2480-2487. PubMed ID: 28720658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
    Wong KSL; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Himmelmann A; Kasner SE; Knutsson M; Ladenvall P; Minematsu K; Molina CA; Wang Y; Johnston SC;
    Stroke; 2018 Jul; 49(7):1678-1685. PubMed ID: 29915123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial.
    Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y; Johnston SC;
    JAMA Neurol; 2020 Nov; 78(2):1-9. PubMed ID: 33159526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
    JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE-2.
    Wang C; Jia W; Jing J; Meng X; Wang A; Xu Q; Zhang X; Pan Y; Xie X; Johnston SC; Bath PM; Lin J; Jiang Y; Li H; Wang Y; Zhao X; Liu L; Li Z; Wang Y;
    J Am Heart Assoc; 2023 Nov; 12(21):e031611. PubMed ID: 37889172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Acute S
    Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
    Int J Stroke; 2019 Oct; 14(7):745-751. PubMed ID: 30747613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
    Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
    JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
    Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KS;
    N Engl J Med; 2016 Jul; 375(1):35-43. PubMed ID: 27160892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
    Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
    JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial.
    Xie X; Jing J; Meng X; Claiborne Johnston S; Bath PM; Li Z; Zhao X; Liu L; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
    Stroke; 2023 Sep; 54(9):2241-2250. PubMed ID: 37548009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
    Wang Y; Chen W; Lin Y; Meng X; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Zhao X; Liu L; Lin J; Dong K; Jing J; Johnston SC; Wang D; Wang Y;
    BMJ; 2019 Jun; 365():l2211. PubMed ID: 31171523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke Recurrence and Antiplatelets in Posterior Versus Anterior Circulation Minor Stroke or Transient Ischemic Attack.
    Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
    Stroke; 2023 Apr; 54(4):964-972. PubMed ID: 36789773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial.
    Xie X; Jing J; Meng X; Johnston SC; Bath PM; Li Z; Zhao X; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
    Stroke; 2024 Jul; 55(7):1739-1747. PubMed ID: 38860396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor versus Clopidogrel in
    Wang Y; Meng X; Wang A; Xie X; Pan Y; Johnston SC; Li H; Bath PM; Dong Q; Xu A; Jing J; Lin J; Niu S; Wang Y; Zhao X; Li Z; Jiang Y; Li W; Liu L; Xu J; Chang L; Wang L; Zhuang X; Zhao J; Feng Y; Man H; Li G; Wang B;
    N Engl J Med; 2021 Dec; 385(27):2520-2530. PubMed ID: 34708996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.